BAL# [001]

Related by string. BAL# [002] * * *

Related by context. All words. (Click for frequent words.) 74 solithromycin 71 ENMD # 71 potent anti angiogenic 70 protein kinase inhibitor 70 pan HDAC inhibitor 70 Thiovir 70 oral prodrug 70 Tarvacin TM 70 delafloxacin 69 sunitinib Sutent ® 69 NEUGENE 69 selective inhibition 69 Vitro Activity 69 vascular disrupting agent 69 Bevirimat 69 HCV protease 69 ON #.Na 69 immunomodulatory 68 CD# monoclonal antibody 68 targeting CD# 68 DAS# [001] 68 Carfilzomib 68 cytoprotective 68 Angiolix 68 Ceftaroline 68 bactericidal activity 68 potent inhibitory 68 Epidermal Growth Factor Receptor 68 REP# 68 glycopeptide 68 Oritavancin 68 Tesetaxel 67 NS4A 67 CYC# 67 radezolid 67 Blinatumomab 67 Vidofludimus 67 Hsp# Inhibitor 67 immunomodulating 67 potent inhibition 67 FGFR 67 DNA intercalator 67 imatinib Gleevec ® 67 Aplidin R 67 Dasatinib 67 EGF receptor 67 antiapoptotic 67 favorable pharmacokinetic profile 67 immune stimulatory 67 PKC# 67 vascular disrupting 67 Bavituximab 67 NS#/#A protease 67 novel peptide 67 selective orally bioavailable 66 Anti Tumor 66 immunostimulatory 66 investigational humanized monoclonal antibody 66 flavopiridol 66 xenograft models 66 replicon 66 CCX# 66 immune modulatory 66 #ME# 66 Akt inhibitor 66 Xanafide 66 bispecific 66 oral antiviral 66 Aurora kinase 66 Mucosal 66 proteasome inhibitors 66 EGFR HER2 66 Kinase Inhibitor 66 S. pyogenes 66 Sphingomab 66 S/GSK# 66 Sym# 66 Symadex 66 Talabostat 66 PTP 1B 66 highly selective inhibitor 66 Gleevec resistant 66 RGB # 66 EGFr 66 Voreloxin 66 NXL# 66 humanized anti 66 Aplidin 66 A3 adenosine receptor 66 Onconase 65 IL #E 65 torezolid 65 5 HT6 receptor 65 PRTX 65 antiproliferative activity 65 AEG# 65 tubulin binding 65 antibody fragment 65 BAL# [002] 65 immunomodulator 65 vinca alkaloid 65 ECCMID 65 anti CD3 65 BiTE 65 Enzastaurin 65 antitumoral 65 Tarvacin 65 Cardiotoxicity 65 IgG1 antibody 65 nucleoside analog 65 protein tyrosine phosphatase 1B 65 retapamulin 65 HuMax EGFr 65 humanized antibody 65 OXi# 65 liposomal formulation 65 orally bioavailable 65 C5aR 65 ganetespib 65 serine protease 65 milatuzumab 65 potent antiproliferative 65 BRAF kinase 65 polymerase inhibitors 65 Protein Kinase C 65 small molecule inhibitors 65 effector function 65 GMX# 65 anti CD# monoclonal 65 tigecycline 65 humanized monoclonal antibodies 65 HuLuc# 65 oncolytic 65 proteasome inhibitor 65 potent antiviral 65 CCR9 65 multi kinase inhibitor 65 SIRT2 65 Interferon alpha 65 anti fibrotic 65 nucleoside analogues 65 CDK inhibitor 65 Deforolimus 65 XmAb# 65 HCV replication 65 Novel Oral 65 TRAIL R2 65 humanized monoclonal 65 Antitumor 65 Nanobody ® 65 Aptamer 65 antiangiogenic activity 65 kinase inhibition 65 MEK inhibitors 65 meropenem 65 immunoregulatory 65 Bafetinib 64 T#I [002] 64 small molecule defensin 64 signal transduction inhibitor 64 selective antagonist 64 tubulin polymerization 64 HDACi 64 antitumor 64 inhibits protein synthesis 64 antiviral activity 64 therapeutic monoclonal antibody 64 T#M 64 Helicobacter pylori H. pylori 64 neurotrophic 64 Azedra 64 Pertuzumab 64 Cytochrome P# 64 humanized monoclonal antibody 64 Tyrima 64 Aurora Kinase 64 Valortim ® 64 cytostatic 64 DXL# 64 anti leukemic 64 IMA# 64 fosbretabulin 64 IAP inhibitor 64 LPA1 receptor 64 telomerase inhibitor 64 selective inhibitor 64 vascular disrupting agents 64 Traficet EN 64 c MET 64 chimeric monoclonal antibody 64 Th1 type 64 Immunohistochemical analysis 64 neutralizing antibody 64 Epratuzumab 64 cMET 64 Cathepsin S 64 OMP #M# 64 Radezolid 64 microtubule targeting 64 selective kinase inhibitor 64 preclinically 64 Monoclonal Antibody 64 nanoviricides 64 depsipeptide 64 rhIL 7 64 anti angiogenic agent 64 beta lactam 64 targeted antifolate 64 Omacetaxine 64 CYT# potent vascular disrupting 64 Elvitegravir 64 immunomodulatory effects 64 potent anticancer 64 anti angiogenic 64 CCR2 64 histone deacetylase HDAC inhibitor 64 phosphate S1P 64 Preclinical Data 64 receptor tyrosine kinase inhibitor 64 HSP# inhibitor 64 Trastuzumab 64 INGN 64 Cytotoxic T 64 Safinamide 64 Antiangiogenic 64 PEGylated 64 monoclonal antibody MAb 64 enzyme inhibitor 64 polymerase inhibitor 64 Preclinical Study 64 pro apoptotic 64 Panzem 64 Epstein Barr Virus EBV 64 CBLC# 64 seliciclib 64 T#I mutant 64 VEGF receptor 63 Zalypsis 63 Valortim R 63 anticancer activity 63 receptor inhibitor 63 secretory phospholipase A2 sPLA2 63 Factor Receptor 63 Galectin 63 Anti Tumor Activity 63 erlotinib Tarceva ® 63 TPI ASM8 63 HER3 63 histone deacetylase inhibitor 63 TRAIL induced apoptosis 63 nanoviricide 63 angiogenesis inhibition 63 Viprovex TM 63 CD# antibody [001] 63 Epothilones 63 monoclonal antibody mAb 63 immune modulating 63 peptide antigens 63 PCK# 63 mertansine 63 PI3K/mTOR 63 JAK inhibitors 63 vidofludimus 63 Nilotinib 63 JVRS 63 tyrosine kinase inhibitor 63 antitumor activity 63 Pathway Inhibitor 63 MET amplification 63 SERMs 63 pharmacokinetic interactions 63 PEG SN# 63 rifamycins 63 neuraminidase inhibitor 63 target enzyme thymidylate 63 Tumor Necrosis Factor 63 selective agonist 63 mitogen activated ERK kinase 63 CXCR4 63 chemotherapeutic drug 63 Irinotecan 63 MAPK pathway 63 Tyrosine Kinase Inhibitor 63 CCR1 63 bactericidal 63 Lpathomab 63 antiproliferative effects 63 Selective Inhibitor 63 myelofibrosis polycythemia vera 63 #th Annual Interscience 63 sodium glucose cotransporter 63 antifibrotic 63 Factor VIIa 63 pathophysiological effects 63 Fleximer 63 CCR9 antagonist 63 immunotoxin 63 anti proliferative 63 Delafloxacin 63 BiTE ® 63 Antiviral Activity 63 Cytomegalovirus CMV 63 HCV NS3 protease 63 NEUGENE antisense 63 Bortezomib 63 PI3 kinase 63 BCR ABL 63 preclinical efficacy 63 ceftazidime 63 TNF receptors 63 vivo efficacy 63 trodusquemine 63 antisense inhibitor 63 Pralatrexate 63 PRT# 63 angiogenesis inhibitor 63 Locked Nucleic Acid LNA 63 Cytotoxic 63 anti amnesic 63 Imatinib 63 kinase inhibitor 63 selective modulator 63 Beta catenin pathway 63 HCV protease inhibitor 63 potent cytotoxic 63 DermaVir 63 Milatuzumab 63 YONDELIS R 63 clade B 63 macrolides 63 antisense inhibition 63 Macrolide 63 MT#/MEDI-# 63 CCR5 antagonist 63 antitumor efficacy 63 FLT3 63 Sapacitabine 63 highly immunogenic 63 antiviral efficacy 63 NS5A 63 HDAC Inhibitor 63 kidney urologic 62 NS5b 62 benzimidazole 62 Chemokine Receptor 62 uricase 62 molecularly targeted 62 inhibitory activity 62 orally administered inhibitor 62 AAV2 62 mda 7 62 INCB# [001] 62 antiangiogenesis 62 peptibody 62 virotherapy 62 Nedd4 62 antigenic peptide 62 HCV replicon 62 TNF α 62 GSK3B 62 tipifarnib 62 Presents Preclinical Data 62 PKC isoforms 62 multidrug resistance 62 HGS ETR2 62 hypoxia inducible factor 62 mGluR2 NAM 62 TRO# 62 fast skeletal troponin 62 androgen receptor AR 62 cytotoxicity 62 beta lactamases 62 Telbivudine 62 Anticalins 62 IgG4 62 Interferon Gamma 62 oxidative stress inducer 62 riociguat 62 PDGF receptor 62 metastatic neuroendocrine tumors 62 Liposomal 62 EpCAM 62 glycopeptides 62 obatoclax 62 YONDELIS 62 Mutational 62 glycosyltransferase 62 potent inhibitor 62 nicotinic acetylcholine receptor 62 JAK1 62 thymidylate synthase TS 62 non nucleoside inhibitor 62 Multimeric 62 nucleotide analog 62 MVA BN R 62 antibody mediated 62 VAX# 62 NPM1 62 Cytotoxicity 62 antiangiogenic 62 HIF PH inhibitors 62 AT1R 62 Eg5 62 Oncogenic 62 Dalbavancin 62 selectively inhibits 62 MEK inhibitor 62 JAK2 inhibitors 62 cleavable linker 62 poly ADP ribose polymerase 62 Guanilib 62 serine threonine kinase 62 DiLA2 62 Alocrest 62 non nucleoside 62 HIF PHI 62 γ secretase 62 CGEN # 62 mAb 62 potent antitumor activity 62 Cyclin E 62 JAK2 enzyme 62 deacetylation 62 Squalamine 62 butyrylcholinesterase 62 mTOR mammalian target 62 Janus kinase 62 C5a 62 virosome 62 Perifosine 62 RANK Ligand 62 tkRNAi 62 Ceflatonin 62 IGFBP2 62 MDRSP 62 Hsp# inhibition 62 TLR7 62 cytotoxin 62 EZN 62 immunotherapeutic 62 fusidic acid 62 ADAMTS# 62 DNA gyrase 62 Hsp# inhibitors 62 Gag polymorphisms 62 antibody MT# 62 Seliciclib 62 neuroprotective properties 62 resolvins 62 JAK inhibitor 62 HER1 62 oral bioavailability 62 pertuzumab 62 chemically modified siRNA 62 Preclinical studies 62 evaluating tivozanib 62 indibulin 62 cellular cytotoxicity 62 Potent Inhibitor 62 lipopeptides 62 Protein Kinase 62 Talactoferrin 62 BAY #-# 62 Virulizin ® 62 PI3K inhibitor 62 hematological cancers 62 Archexin 62 erythropoietic 62 TGF ß 62 Tigecycline 62 peptide conjugated 62 histone deacetylase HDAC 62 allosteric modulation 62 daptomycin 62 angiotensin receptor blocker ARB 62 talabostat 62 DepoVax 62 anti CD# antibody 62 Fc fusion protein 62 DermaVir Patch 62 irreversible inhibitor 62 EphA2 62 alpha folate receptor 62 Th# 62 tuberculosis bacterium 62 Denufosol 62 antisense inhibitors 62 Maribavir 62 cytotoxic 62 TGF beta1 62 activin 62 chemokine receptor 62 HDAC6 62 Nanobody 62 MUC1 62 neuroprotectant 62 GV# [001] 62 thalidomide Thalomid 62 Plasmodium vivax 62 TLR9 agonist 62 HER2/neu 62 accumulate preferentially 62 Bosutinib 62 cyclophilin inhibitor 62 interferon IFN 62 immunotoxins 62 apoptosis inducing 62 virulence genes 61 novel orally bioavailable 61 HTS assay 61 IMPDH 61 Panzem R 61 Personalized Immunotherapy 61 TTR gene 61 Survivin 61 synthase TS 61 VEGFR2 61 #HT#A 61 Alfacell proprietary ribonuclease 61 vitro assay 61 induces apoptosis 61 Protease Inhibitor 61 orally dosed 61 Transcription Factor 61 Golimumab 61 Olaparib 61 demethylating agent 61 mTOR inhibitors 61 Zysolin TM 61 Anidulafungin 61 Anti angiogenic 61 HQK 61 topoisomerase II 61 VDAs 61 M1 muscarinic 61 Daptomycin 61 LHRH antagonists 61 epithelial tumors 61 prophylactic vaccine 61 RNAi mediated 61 Moxifloxacin 61 gastrin 61 sphingosine kinase 61 GRN#L 61 HDAC 61 IRX 2 61 small molecule activator 61 fluoroquinolone resistance 61 PSMA ADC 61 single stranded oligonucleotides 61 davunetide intranasal AL 61 FUS1 61 TLE3 61 methicillin resistant S. aureus 61 POTELLIGENT ® 61 inhibitor RG# 61 ANG# 61 beta lactamase inhibitor 61 outer membrane proteins 61 oral JAK1 61 E3 ligase 61 CDDO Im 61 ALN TTR 61 Imprime PGG 61 inhibitory effects 61 Darinaparsin 61 cyclin dependent kinases CDKs 61 intratumoral injection 61 deacetylase inhibitors 61 superantigens 61 small molecule activators 61 TNFα 61 RNAi Therapeutic 61 c Src 61 vivo validation 61 pRb 61 OncoVEX 61 RAS RAF MEK 61 Fc receptor 61 BRAF inhibitors 61 DHFR 61 AP# [003] 61 p# MAP kinase 61 PI3K/Akt pathway inhibitor 61 trastuzumab Herceptin 61 Boceprevir 61 Factor Xa 61 dopamine D2 61 H pylori 61 proapoptotic 61 hematological tumors 61 maturation inhibitor 61 FGFR1 61 XL# inhibits 61 Romidepsin 61 Kahalalide F 61 multitargeted 61 oral FTY# 61 Dapagliflozin 61 lysophosphatidic acid LPA 61 virus HCV protease inhibitor 61 Hepatitis C Virus HCV 61 HDAC enzymes 61 CYT# 61 ARRY # 61 partial agonist 61 nucleotide analogs 61 M2 subunit 61 MEK ERK 61 ADP receptor antagonist 61 CTGF 61 vimentin 61 cathepsin K inhibitor 61 NS5B polymerase 61 Disease Progression 61 tumor vasculature 61 alpha7 61 P#X# 61 Androgen Receptor 61 amino acid substitution 61 assay detects 61 Litx 61 ocular formulation 61 oritavancin 61 dimeric 61 CK2 61 CG# [003] 61 UPLYSO 61 reversible inhibitors 61 IFN α 61 huC# DM4 61 HGF c Met 61 protein tyrosine phosphatase 61 JAK2 inhibitor 61 TG# [003] 61 Cethromycin 61 entinostat 61 MT1 MMP 61 Therapeutic Vaccine 61 echinocandins 61 biofilm formation 61 synuclein 61 IMiDs R 61 fusion protein 61 anionic backbone 61 APOPTONE 61 Tarvacin Anti Viral 61 FK# 61 matrix metalloproteases 61 velafermin 61 JAK#/JAK# 61 BRAF inhibitor 61 Erlotinib 61 chemopreventive agent 61 Bruton tyrosine kinase 61 Adenoviral 61 ATL/TV# 61 ara C 61 peptidic compound 61 Kinase Inhibitors 61 granzyme 61 gemcitabine Gemzar 61 oncolytic virus 61 pneumoniae PRSP 61 vitro cytotoxicity 61 LPA1 61 antisense oligonucleotide 61 novel VDA molecule 61 Histone Deacetylase 61 UsiRNAs 61 CTLA 4 61 PEGylated interferon 61 multikinase inhibitor 61 carbapenem 61 fluoroquinolone antibiotic 61 methicillin susceptible Staphylococcus aureus 61 adipogenic 61 bioactive lipids 61 GW# [003] 61 p#/CBP 61 EGFR receptor 61 ZK EPO 61 Immunotherapeutic 61 mapatumumab 61 lentiviral vector 61 tumor necrosis 61 SSc 61 EndoTAG TM -1 61 Methylnaltrexone 61 p# inhibitor 61 interleukin IL -# 61 Vorinostat 61 opioid receptor antagonist 61 aminoglycoside 61 TNFa 61 Debio 61 Viprovex 61 peroxidase 61 potent inhibitors 61 Glufosfamide 61 Receptor Antagonist 61 vorinostat 61 alkylating agent 61 B lymphocyte stimulator 61 Staphylococcal 61 aberrantly activated 61 delipidation 61 pegylated 61 E. faecalis 60 FGFR4 60 Rigel R# 60 Interferon Beta 60 MLN# 60 radiation sensitizer 60 FasL 60 Pentraxin 2 60 thrombopoietin 60 Polymerase 60 posaconazole 60 HER2 receptor 60 antitumor effects 60 topoisomerase II inhibitor 60 Pharmacokinetics PK 60 mediated inhibition 60 Streptococcus pyogenes 60 bacterial enzyme 60 Everolimus 60 anticancer therapies 60 GPx 60 dasatinib Sprycel 60 CXCR4 receptor 60 CR# vcMMAE 60 TG# [001] 60 Ceflatonin R 60 TAFA# 60 Upregulation 60 HGS ETR1 60 Secretase 60 targeted radiotherapeutic 60 Initiates Clinical 60 CA4P 60 Anticalin ® 60 Valortim 60 tubulin inhibitor 60 E#F# 60 histone deacetylase 60 NKG2D 60 MTP inhibitor 60 Fulvestrant 60 Bcr Abl mutations 60 HCV genotypes 60 AKT inhibitor 60 pharmacodynamic properties 60 Interferons 60 Prolongs Survival 60 AZT zidovudine Retrovir 60 influenza VLP vaccine 60 novel immunomodulatory 60 PDGF B 60 siRNA mediated 60 HCV polymerase 60 Histone 60 RAV# 60 macrolide antibiotics 60 anticancer agent 60 immunomodulatory properties 60 factor receptor FGFR 60 potent suppressor 60 metaglidasen 60 c MYC 60 murine monoclonal antibody 60 adenoviral vectors 60 HGS ETR1 mapatumumab 60 Granulocyte Colony Stimulating Factor 60 Thiarabine 60 Palifosfamide 60 Adenosine 60 Quantitation 60 dihydrofolate reductase 60 Factor VEGF 60 HDAC inhibition 60 subtype selective 60 LRP5 60 immunological responses 60 CD# expressing 60 GSK3 60 BNC# 60 vitro studies 60 taxane derivative 60 beta lactam antibiotic 60 plasma kallikrein inhibitor 60 IFN alpha 60 CD# CD# 60 RAF kinase 60 Klebsiella pneumonia 60 systemic RNAi therapeutic 60 HDAC inhibitor 60 Clusterin 60 ritonavir boosted 60 demonstrated antitumor activity 60 beta lactams 60 inhibit replication 60 Elesclomol 60 chlamydial 60 Kinases 60 vWF 60 N. gonorrhoeae 60 IgG1 60 GSOs 60 LJ# [002] 60 TCAD therapy 60 B7 H3 60 dAbs 60 agonism 60 TriRima 60 synthetic peptides 60 cell lysis 60 beta lactam antibiotics 60 RNase L 60 histone acetyltransferase 60 potently inhibited 60 nucleoside 60 innate immune responses 60 Quinamed 60 p#NTR 60 Lenalidomide 60 chemoresistance 60 DACH platinum 60 CXCR7 60 trabectedin 60 pDC 60 Tyrosine Kinase 60 pharmacological chaperone 60 Bendavia 60 systemic antifungal 60 hydrolase 60 recombinant subunit vaccine 60 interferon γ 60 ImmunoVEX HSV2 60 sclerostin 60 anti phosphatidylserine 60 dimerization 60 potently inhibit 60 colorectal carcinoma 60 OHR/AVR# 60 Hedgehog signaling pathway 60 selectively inhibit 60 IGF 1R 60 Hedgehog signaling 60 PXD# 60 tumor vascular disrupting 60 R#/MEM # 60 Abl 60 Gefitinib 60 Macrophage 60 cancer vaccine Norelin 60 Nanobodies ® 60 EGFR tyrosine kinase inhibitors 60 oncogenic 60 TLR8 60 enzyme inhibitors 60 Ampligen ® 60 pleiotropic 60 linezolid resistant 60 Hedgehog pathway 60 cytotoxic effects 60 itraconazole Sporanox 60 Pharmacodynamic 60 Phase Ib II 60 siRNA therapeutics 60 OncoVEX GM CSF 60 Cyclosporine 60 fatty acid biosynthesis 60 Elotuzumab 60 mTOR kinase 60 Interferon beta 60 Superoxide 60 phosphatases 60 CD# ligand 60 integrase enzyme 60 varicella zoster virus 60 DepoVax TM 60 anthrax toxin 60 mu opioid receptor antagonist 60 herpesviruses 60 IMiDs ® compound 60 AZD# ARRY # 60 ENMD 60 Nitazoxanide 60 imatinib resistance 60 EGFR inhibitors 60 hormone gastrin 60 P#Y# [002] 60 Protein Expression 60 Pazopanib 60 Bruton tyrosine kinase Btk 60 AVI NEUGENE 60 PDE4 inhibitor 60 somatostatin analogue 60 antitumour 60 p# biomarker 60 FGFR3 60 filoviruses 60 Systemic Delivery 60 investigational HCV polymerase 60 novel histone deacetylase 60 antiviral compounds 60 NS3 protease 60 Anticalin R 60 CagA 60 2 methoxyestradiol 60 Cloretazine R 60 Azixa 60 alpha#beta# integrin 60 M2e 60 BZL# 60 naturally occurring molecule 60 MMP9 60 glucagon receptor 60 PSN# [002] 60 anticancer compound 60 receptor tyrosine kinase 60 HCV protease inhibitors 60 proteasome inhibitor bortezomib 60 proto oncogene 60 AMN# [001] 60 IgG antibodies 60 potent antibacterial 60 iRGD 60 GLYX 60 tumorigenicity 60 spectrum beta lactamases 60 Tissue Factor 60 HAAH 60 Exherin TM 60 DiLA2 Platform 60 exosome 60 Kinoid 60 Alinia 60 PROSTASCINT R 60 mediated apoptosis 60 SGLT2 60 antimetastatic 60 costimulatory 60 potent bactericidal activity 60 arenaviruses 60 Corgentin 60 hepatoma 60 HDL Mimetic Peptide 60 anticancer therapeutics 60 Monoclonal 60 Lenocta 60 sCD# 60 dependent cellular cytotoxicity 60 mAbs 60 FKBP# 60 specific protein tyrosine 60 LSD1 60 TNFalpha 60 thymidylate synthase 60 Annamycin 60 pegylated interferons 60 adenoviral 60 multivalent vaccine 60 amikacin 60 HER2 antibody 60 immuno modulatory 60 azoles 60 IL #p# 60 Flt3 60 antiviral potency 60 Ii protein 60 homodimers 60 Bevacizumab 60 mTOR inhibitor 60 Neugene 60 Radilex 60 glycosylated 60 Inhibitor 60 Epitope 60 CEQ# 60 Raltegravir 60 RhuDex ® 60 small molecule tyrosine 60 Burkholderia pseudomallei 60 gastrointestinal stromal tumors GIST 60 transgenic mouse models 60 virus AAV 60 5 HT2A receptor 60 G Protein Coupled 60 molecule epidermal 60 VZV 60 MGCD# [001] 60 ongoing Phase 1b 60 #beta HSD 1 60 bicalutamide 60 BMS# 60 NS3 59 peripherally acting

Back to home page